Your browser doesn't support javascript.
loading
Prognostic histological markers in oral tongue squamous cell carcinoma patients treated with (chemo)radiotherapy.
Hyytiäinen, Aini; Mroueh, Rayan; Peltonen, Johanna; Wennerstrand, Pia; Mäkitie, Antti; Al-Samadi, Ahmed; Ventelä, Sami; Salo, Tuula.
Afiliação
  • Hyytiäinen A; Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki, Finland.
  • Mroueh R; Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Peltonen J; Department of Otorhinolaryngology - Head and Neck Surgery, University of Helsinki and HUS Helsinki University Hospital, Helsinki, Finland.
  • Wennerstrand P; Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer and Research, Helsinki, Finland.
  • Mäkitie A; Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki, Finland.
  • Al-Samadi A; Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Ventelä S; Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki, Finland.
  • Salo T; Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
APMIS ; 131(4): 142-151, 2023 Apr.
Article em En | MEDLINE | ID: mdl-36695633
ABSTRACT
Treatment of oral tongue squamous cell carcinoma (OTSCC) frequently includes surgery with postoperative radiotherapy (RT) or chemoradiotherapy (CRT). Resistance to RT or CRT remains a major clinical challenge and highlights the need to identify predictive markers for it. We included 71 OTSCC patients treated with surgery combined with RT or CRT. We evaluated the association between tumor budding, tumor-stroma ratio (TSR), depth of invasion (DOI), tumor-infiltrating lymphocytes (TILs), hypoxia-inducible factor-1alpha (HIF-1alpha) expression, octamer-binding transcription factor 4 (OCT4) expression, high-endothelial venules (HEVs), and disease-free survival (DFS) using uni- and multivariate analyses. No significant association was observed between the different histological and molecular markers (TSR, DOI, TILs, HEV, HIF-1alph, OCT4) and DFS. However, an associative trend between DOI, budding, and DFS was noted. Further studies with larger cohorts are needed to explore the prognostic value of DOI and budding for OTSCC patients treated with postoperative RT or CRT.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Língua / Carcinoma de Células Escamosas / Neoplasias de Cabeça e Pescoço Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: APMIS Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Língua / Carcinoma de Células Escamosas / Neoplasias de Cabeça e Pescoço Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: APMIS Ano de publicação: 2023 Tipo de documento: Article